Parathyroid hormone-related protein (PTHrP) plays a primary role in the development of humoral hypercalcemia of malignancy seen in the majority of adult T-cell leukemia/lymphoma (ATLL) patients with human T-cell lymphotropic virus type-1 (HTLV-1) infection. HTLV-1 Tax has been shown to complex with ETS-1 and SP1 to transactivate the PTHrP P3 promoter. Previously, we established a SCID/bg mouse model of human ATL with RV-ATL cells and showed that PTHrP expression was independent of Tax. In this study, we report an inverse correlation of PTHrP with tax/rex mRNA in multiple HTLV-1-positive cell lines and RV-ATL cells. Stimulation of Jurkat T cells with PMA/ionomycin upregulated the PTHrP P3 promoter by a previously characterized Ets binding site and also induced protein/DNA complex formation identical to that observed in RV-ATL cells. Further, we provide evidence that cotransfection with Ets-1 and constitutively active Mek-1 in HTLV-1-negative transformed T cells with stimulation by PMA/ionomycin not only resulted in a robust induction of PTHrP P3 but also formed a complex with ETS-1/P3 EBS similar to that in ATLL cells. Our data demonstrate that transcriptional regulation of PTHrP in ATLL cells can be controlled by T-cell receptor signaling and the ETS and MAPK ERK pathway in a Tax-independent manner.
Introduction
Adult T-cell leukemia/lymphoma (ATLL) is an aggressive and often fatal malignancy of mature helper T cells infected with human T-cell lymphotropic virus type-1 (HTLV-1) 1 that develops in chronically infected individuals 20-50 years following initial infection. About 80% of ATL patients develop humoral hypercalcemia of malignancy (HHM). HHM is a life-threatening paraneoplastic syndrome seen in a wide variety of cancers 2 in addition to ATLL. HHM develops in cancer patients with increased circulating parathyroid hormone-related protein (PTHrP) that stimulates parathyroid hormone-1 receptors (PTH1R) to induce osteoclastic bone resorption and increase calcium reabsorption in kidneys, resulting in hypercalcemia. 3 In addition to its role in the induction of HHM, PTHrP has been shown to be involved in the regulation of cell proliferation and apoptosis in a wide variety of normal and neoplastic tissues. [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] The human PTHrP gene is composed of nine exons spanning more than 15 kilobases of genomic DNA and 15 different transcripts can be generated by alternative splicing of the 5 0 and 3 0 exons. Nevertheless, all PTHrP transcripts share products of exons 5 and 6 that encode for the prepro region and the majority of the mature peptide. PTHrP transcription is regulated by three distinct promoters identified as P1, P2 and P3. P1 and P3 contain a typical TATA box, [16] [17] [18] while P2 is a GC-rich promoter region. 19 Previous evaluation of PTHrP alternative promoter usage by qualitative 20, 21 and quantitative reverse transcription (RT)-PCR 22 revealed that P3-initiated transcripts were detectable at high levels in most tumors and cell lines examined, including the (HTLV-1)-positive cell line MT-2, whereas P1 or P2-derived transcripts were not detected or expressed only in a subset of tumors.
Tax is a 40-kDa nuclear-localizing phosphoprotein, encoded from open reading frame IV of HTLV-1 that induces transcription of viral and numerous cellular genes such as IL-2, 23 IL-2 receptor a, 24 c-fos, 25 and c-myc 26 through activation of cyclic AMP response element binding protein (CREB/ATF), NF-kappaB (NFkB) and serum response factor (SRF). Rex is encoded from ORFIII and regulates viral gene expression by interacting with cis-acting elements called the Rex-responsive element (RxRE) present in the 3 0 and 5 0 long terminal repeat (LTR), 27, 28 which determines the level of expression of the virion components. Previous reports showed that Tax could transactivate PTHrP transcription in vitro. [29] [30] [31] A physical interaction between Tax and transcription factor Ets-1 was reported, and it was shown that their coexpression enhanced PTHrP P3 transcriptional activation in an osteosarcoma cell line, OsA-CL. 32 However, tax/rex mRNA expression is undetectable or present at very low levels in ATLL cells in vivo. 33, 34 These results suggest that stimuli other than HTLV-1 Tax are likely involved in PTHrP transcriptional regulation in ATLL cells. Furthermore, IL-2 upregulates PTHrP gene expression and secretion in ATLL cells via both transcriptional activation and increased mRNA stability. 35, 36 Still, little is known about the regulation of PTHrP gene expression and its transcriptional activation in ATLL cells in vivo.
Expression of Ets-1, a member of the Ets family of transcription factors, is limited to lymphoid tissues in adults, 37 including mature T cells. Activation of Ets-1 occurs via Ras-mitogen activated protein kinase (MAPK) signaling involving Mek-1 and Erk-1/2 kinases. Activated Ets-1 was shown to transactivate PTHrP using an Ets-binding site in P3 in breast cancer cells, [38] [39] [40] murine keratinocytes 41 and HTLV-1-infected cells. 30 We have previously reported that severe combined immunodeficient (SCID)/beige (bg) mice inoculated with ATLL cells develop solid lymphoma and HHM characterized by severe hypercalcemia, increased osteoclastic bone resorption, decreased bone mineral density and increased circulating PTHrP that correlated positively with plasma calcium concentrations.
Xenografted ATLL cells (RV-ATL) expressed very high levels of PTHrP mRNA as compared to other HTLV-1 positive cell lines. In addition, HTLV-1 Tax protein and tax/rex mRNA were not detectable by Western blotting and RT-PCR in RV-ATL xenografted cells, but were expressed at high levels in other HTLV-1-infected cell lines. Altogether, our results demonstrated that HHM could develop due to an increase in circulating PTHrP concentrations independent of HTLV-1 Tax in ATLL.
In the present study, we compared PTHrP to tax/rex mRNA expression levels and determined the alternative PTHrP promoter usage in ATLL cells xenografted in SCID/bg mice and four HTLV-1-positive cell lines using real-time RT-PCR. We also characterized and demonstrated a constitutive protein/DNA complex formation on a composite region of the previously characterized Ets-binding site and a potential g-interferonactivated site (GAS) located within the third promoter (P3) of the human PTHrP gene in HTLV-1-infected cells. Finally, we present evidence that transactivation of the PTHrP P3 promoter can occur in HTLV-1-negative transformed human T cells via activation of Ets-1 with an EBS after T-cell stimulation with combined phorbol-12-myristate-13-acetate (PMA) and ionomycin or coexpression of Ets-1 with a constitutively active MAPK Mek-1 mutant in a Tax-independent manner.
Materials and methods

Animals and inoculation
Homozygous C.B-17/IcrCrl-scid-bgBR (SCID/bg) immunodeficient mice were purchased from Charles River Laboratories (Wilmington, MA, USA) and maintained under specific pathogen-free conditions in the animal facility of the College of Veterinary Medicine at The Ohio State University (Columbus, OH, USA). Male mice aged 5 weeks were used as recipients, anesthetized with xylazine-ketamine, and injected intraperitonally with 2-4 Â 10 7 RV-ATL cells suspended in RPMI 1640 medium. The source of the RV-ATL cell line was previously described. 43 Approximately 1 Â 10 7 RV-ATL cells were collected between 21 and 28 days postinoculation by peritoneal lavage. 42 
Cell lines
MT-2, SLB-1, Jurkat T and HUT-102 cells were cultured in RPMI 1640 media supplemented with 10% heat-inactivated (561C, 30 min) FBS, L-glutamine (2 mM), penicillin (50 U/ml) and streptomycin (50 mg/ml) (Invitrogen, Carlsbad, CA, USA), at 371C and 5% CO 2 . HT1-RV cells were maintained in Iscovés medium supplemented with 20% FBS, L-glutamine, penicillin and streptomycin.
Real-time RT-PCR
Total RNA was extracted with TRIzol reagent (Invitrogen, San Diego, CA, USA). Quantitative evaluation of HTLV-1 tax/rex and PTHrP mRNA expression and alternative promoter usage was performed as previously described. 22 RT reactions were carried out with 5 mg of total RNA according to the manufacturer's protocol using oligo(dT) [12] [13] [14] [15] [16] [17] [18] and 50 U of Superscript II reverse transcriptase (Invitrogen) and were diluted to 50 ml after RT. cDNA standards were prepared by PCR amplification of cDNA from human lung carcinoma cells BEN (PTHrP and b2-microglobulin) or MT-2 cells (tax/rex standards) and calibrators ranging from 250 to 2.5 Â 10 8 copies/ml were prepared by serial dilution. The following primers were used for tax/rex transcript (tax1.fw; 5 0 -ccgccgatcccaaagaaa-3 0 /tax1.rv; 5 0 -ccgaacatagtcccccaga-3 0 , exon 2/3, 144-bp amplicon). Data were normalized using the ratio of the target cDNA concentration to b 2 -microglobulin.
Preparation of nuclear extracts
Cells (0.5-1 Â 10 7 ) were washed twice with cold phosphatebuffered saline and cell pellets were resuspended in 500-600 ml of hypotonic buffer A (10 mmol/l HEPES, pH 8.0, 10 mmol/l KCl, 1.5 mmol/l MgCl 2 , 0.1 mmol/l EDTA, 1 mmol/l dithiothreitol (DTT), 0.5 mmol/l phenylmethylsulfonyl fluoride (PMSF) and 0.065% Nonidet P-40) for 10 min at 41C. Nuclei were isolated by microcentrifugation (800 rpm) for 4 min at 41C. The nuclear pellet was suspended in 75-100 ml of extract buffer C (20 mmol/l HEPES, pH 8.0, 400 mmol/l NaCl, 1.5 mmol/l MgCl 2 , 1 mmol/l EDTA, 1 mmol/l DTT, 20% glycerol, 33 mg/ml aprotinin, 10 mg/ ml leupeptin, 10 mg/ml pepstatin, 50 mmol/l sodium fluoride and 1.5 mmol/l sodium orthovanadate) and incubated for 30 min at 41C with continuous gentle mixing. The mixture was microcentrifuged (14 000 rpm) for 30 min at 41C. Protein concentrations of nuclear extracts were determined using the Bradford assay (Pierce, Rockford, IL, USA).
Oligonucleotides and electrophoretic mobility shift assay
Double-stranded PTHrP P3 wild type (sense strand; 5 0 -gatct caactttccggaagcaacca-3 0 ), P3 GAS mutant (sense strand; 5 0 -gatctcaacttagcggaagcaacca-3 0 , GAS element is underlined), P3 EBS mutant (sense strand; 5 0 -gatctcaactttccgttagcaacca-3 0 , ETS-binding element is underlined) and P3 GAS/EBS mutant (sense strand; 5 0 -gatctcaacttagcgttagcaacca-3 0 ) oligonucleotides were prepared by annealing and fill-in reaction using [a- 32 P] or nonradiolabeled deoxyadenosine triphosphate in the presence of the Klenow fragment of DNA polymerase I. Oligonucleotides containing known consensus for ETS family, STAT-1, STAT-3 and STAT-5 (Santa Cruz Biotechnology, Santa Cruz, CA, USA) were end-labeled using T4-polynucleotide kinase (Invitrogen) in the presence of [g-32 P]adenosine triphosphate. Nuclear extracts (7.5 mg of protein) were incubated in 18 ml total reaction volume, containing 10 mmol/l Tris-HCl, pH 7.5, 50 mmol/l NaCl, 1 mmol/l EDTA, 1 mmol/l DTT, 10% glycerol, 1 mg of poly(dIdC) Á poly(dI-dC) (Amersham Biosciences, Piscataway, NJ, USA) and 0.4 ml/ml bovine serum albumin for 15 min at room temperature. The reaction mixture was then incubated with the radiolabeled oligonucleotide (50 000 cpm) alone or with 25-fold excess of nonradiolabeled oligonucleotide for 15 min at RT. Samples were analyzed by electrophoresis using 4% nondenaturing polyacrylamide gels with 0.25 Â TBE buffer (22.3 mmol/l Tris, 22.2 mmol/l boric acid and 0.5 mmol/l EDTA). The gels were dried and analyzed by autoradiography.
Plasmids and site-directed mutagenesis
A human PTHrP P3-luciferase reporter gene construct, originally identified as the BglI-HindIII construct, 44 was used in luciferase expression assays. It was derived from human P3 promoter PTHrP-CAT constructs 19 and cloned into pGL-2 basic vector (Promega, Madison, WI, USA). Constructs bearing mutations in Regulation of PTHrP in ATLL V Richard et al the GAS element, ETS (EBS) and SMAD-binding sites (SBS) were generated with the QuickChanget Site-Directed Mutagenesis Kit (Stratagene, La Jolla, CA, USA) and the following primers (mutations indicated with italic letters); EBS-mutant (sense strand: 5 0 -gtggaatcaactttccgttagcaaccagcccaccag-3 0 ), GAS-mutant (sense strand: 5 0 -gtgtgtggaatcaacttagcggaagcaaccagccc-3 0 ), GAS/EBSmutant (sense strand: 5 0 -gggtgtgtggaatcaacttagcgttagcaaccagccca ccagagg-3 0 ), SBS-mutant (sense strand: 5 0 -gaggaggtagggaggtaga tacatagctatgtatatatatgtggg-3). Sequences in mutant plasmids were confirmed with an Applied Biosystems automated 3700 DNA Analyzer. The pcDNA-3-based expression vectors of Ets-1 (pcEts-1) and constitutively active Mek-1 (pMek-1-DE) have been described previously 45, 46 and were a kind gift of Dr M Ostrowski, The Ohio State University. pbgal-control vector (BD Biosciences, San Jose, CA, USA) was used as an internal control to correct for transfection efficiency in all experiments.
T-cell transfection and stimulation
Approximately 2.5 Â 10 6 Jurkat T cells were electrotransfected in a BioRad Gene Pulser II (250 V, 950 mF) with 5 mg of wild type or mutant (m1-m7) PTHrP P3-luc constructs. Cells were either left untreated or stimulated with 20 ng/ml PMA (Sigma, St Louis, MO, USA) and 2 mM ionomycin (Sigma) at 6 h post-transfection, followed by an 18-h incubation period prior to lysis for measurement of luciferase and b-galactosidase activities. For EMSA studies, Jurkat T cells were maintained at 5 Â 10 5 cells/ml in RPMI supplemented with 10% FBS and were stimulated with PMA or ionomycin alone or in combination for a period ranging from 15 to 60 min prior to nuclear extract preparation. To investigate the effect of Ets-1 and Mek-1 on PTHrP transcriptional regulation, Jurkat T cells were cotransfected with 5 mg of wild type or EBS mutant (m2 and m7) P3-luc constructs in the presence or absence of expression plasmids pcEts1 (0-8 mg) or pcDNA-3 (10 mg), and/or pMek-1-DE (2.5 mg). Different groups were stimulated with PMA and ionomycin at 30 h posttransfection, followed by an 18 h incubation. In all cases, the plasmid pbgal-Control Vector (2 mg) was cotransfected and served as internal control to correct for transfection efficiency. Transfected cells were lysed after 48 h in 100 ml of passive lysis buffer (Promega). Luciferase activity was measured with the Luciferase Assay System (Promega) using 50 ml of lysate. Simultaneously, b-galactosidase activity was measured with the Luminescent b-Galactosidase Detection Kit II (BD Biosciences). Each reporter assay experiment was repeated at least three times.
Statistical analysis
Comparison between groups in luciferase expression assays was performed using the nonparametric Mann-Whitney U-test and Student's t-test (two-tailed) with Po0.05 considered significant. Statistical analysis was performed using Instat 3.01 (GraphPAD software).
Results
A strong inverse correlation between PTHrP and tax/rex mRNA expression was observed in HTLV-1-positive cell lines and RV-ATL cells
We compared PTHrP to HTLV-1 tax/rex mRNA expression in five different HTLV-1 positive cell lines using quantitative realtime RT-PCR. First, we examined PTHrP gene expression using primers to amplify products of exons 5 and 6, which are common to all PTHrP mRNA species regardless of their respective 5 0 or 3 0 alternative splicing. RV-ATL cells engrafted in SCID/bg mice showed the highest PTHrP mRNA expression among the HTLV-1 cell lines tested. Comparatively, PTHrP mRNA expression in MT-2, SLB-1, HT1-RV and Hut-102 was lower and corresponded to 15, 13, 6 and 1% of its expression in RV-ATL cells, respectively (Figure 1) . Simultaneously, we also measured HTLV-1 tax/rex gene expression in the same samples using primers amplifying doubly spliced viral RNA encoding for the tax and rex gene products. We observed that tax/rex mRNA expression was greater in HT1-RV cells when compared to the other cell lines tested. Hut-102, MT-2 and SLB-1 cells expressed moderate levels of tax/rex mRNA representing 13, 8 and 7% of the expression observed in HT1-RV cells. The level of tax/rex gene expression in RV-ATL cells was at the limit of detection of our assay and corresponded to less than 1% of levels detected in HT1-RV cells. Final real-time PCR products were of expected size when separated on a 2% agarose gel by electrophoresis. In addition, the intensity of the bands correlated well with the quantitative data obtained from the LightCycler. The quantitative real-time RT-PCR results in cell lines examined confirmed our previous qualitative evaluation of PTHrP gene expression by standard RT-PCR (data not shown) using primers published previously. 20 Ratios of PTHrP to tax/rex mRNA expression in cell lines examined were also determined. HT1-RV and Hut-102 cells had ratios (PTHrP:tax/rex) of 1:200 and 1:167, whereas the ratios in MT-2, SLB-1 and RV-ATL cells were 1:10, 1:7 and 89:1, respectively. Our data demonstrate a strong inverse correlation between both transcripts in HTLV-1-positive cells. 
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in all HTLV-1-positive cell lines and RV-ATL cells when compared to copy numbers measured for P2 or P3-derived transcripts (Figure 2 ). Cells expressing high PTHrP mRNA levels (RV-ATL, SLB-1 and MT-2) had P2:P3 ratios ranging from 1:6 to 1:8. In contrast, P2:P3 ratios were 2:1 and 5:1 in HT1-RV and Hut-102 cells, which express low levels of PTHrP mRNA. Quantitative real-time RT-PCR data evaluating the alternative promoter usage correlated well with our previous observations using standard RT-PCR (data not shown). The results demonstrated that HTLV-1-positive cells expressing high levels of tax/rex mRNA have a P2:P3 ratio in favor of P2-derived transcripts in contrast to a predilection for usage of the P3 promoter in cell lines expressing modest to low levels of tax/rex mRNA.
Constitutive and Ets-specific binding to PTHrP P3 in HTLV-1-positive cell lines and RV-ATL cells Constitutive formation of a distinct ETS-specific protein-DNA complex (C1) on the composite GAS/EBS regulatory element located within the third promoter (P3) of human PTHrP gene was revealed by EMSA using nuclear extracts from RV-ATL cells xenografted in SCID/bg mice (lane 1) (Figure 3a) . A second protein-DNA complex (C2) was formed with a mutant oligonucleotide (lane 2) containing a disrupted EBS motif (GAS/ebs). Formation of the ETS-specific protein-DNA complex (C1) was markedly reduced in the reaction with a mutant oligonucleotide (lane 3) containing a disrupted GAS element (gas/EBS).
Comparison of the complexes formed between the P3 oligonucleotide and other oligonucleotides with consensus sequences for Ets-1 (lane 4), STAT-1 (lane 5), STAT-3 (lane 6) and STAT-5 (lane 7) suggested that a protein-DNA complex formed on the Ets-1 oligonucleotide was identical to the C1 complex, while the C2 complex was the same as the protein-DNA complex associated with the STAT-5 oligonucleotide. Examination of protein-DNA complex formation on the P3 GAS/EBS element in other HTLV-1-positive cells and Jurkat T cells revealed constitutive formation of complex C1 that was fully abolished with the addition of 25-fold excess of nonradiolabeled P3 oligonucleotide (Figure 3b) . Complexes with the highest intensity were observed in RV-ATL cells followed by MT-2, SLB-1 and Hut-102 cells, whereas the intensity of C1 complexes was lower in HT1-RV and Jurkat T-cells. Formation of C2 complexes with the GAS/ebs oligonucleotide was seen only in RV-ATL, MT-2 and SLB-1 cells. C1 complex formation was partially abolished when mutant oligonucleotide gas/EBS was tested. The oligonucleotide containing a mutation in both GAS and EBS elements (gas/ebs) fully prevented the formation of C1 and C2 complexes in all cell lines tested. Taken together, these results strongly supported that a constitutive EBS-specific DNA-binding complex (C1) formed with Ets transcription factor(s) in all HTLV-1-positive cell lines tested, and that a second complex (C2) containing STAT-5 could form when the EBS element was disrupted, suggesting that a factor(s) in the complex C2 had a lower affinity or was simply present at lower concentrations than Ets transcription factor(s) included in complex C1. Constitutive activation of Ets factor(s) in HTLV-1-positive and Jurkat T cells. (a) Nuclear extracts of xenografted RV-ATL cells formed two protein/DNA complexes (C1 and C2) when subjected to EMSA using oligoprobes to PTHrP P3 wild-type GAS/EBS (lane 1), P3 GAS/EBS mutant (italic) oligos (lanes 2-3) and ETS-1, STAT1, STAT3 and STAT5 consensus sequences (lanes 4-7) as a probes. (b) Nuclear extracts from RV-ATL, MT-2, SLB-1, Hut-102, HT1-RV and Jurkat T cells were subjected to EMSA with PTHrP GAS/EBS wild type and mutant oligoprobes. 25-fold excess of unlabeled wild-type probe was used as competitor.
Stimulation of
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V Richard et al promoter P3 and stimulated with PMA and ionomycin. There was a 5.5-fold induction of luciferase activity with wild-type PTHrP P3-luciferase construct in Jurkat T cells in response to PMA and ionomycin stimulation (Figure 4a) . A 2.5-fold increase in luciferase activity was observed in cells stimulated with either ionomycin or PMA. Luciferase activity of a series of mutant PTHrP P3-luciferase constructs (m1-m7) carrying point mutations that disrupted the GAS, EBS and SBS elements individually or in combination was compared to that of the wild-type construct (Figure 4b ). Lysates from Jurkat T cells transfected with mutants containing a disrupted EBS (m2, m5, m6 and m7) and costimulated with PMA and ionomycin resulted in a 65-73% decreased luciferase activity compared to the wild-type construct. Stimulation with PMA/ionomycin with the plasmids containing mutations resulted in a 78-83% decrease in luciferase activity. Interestingly, transfection with mutants containing disruption of the GAS and/or SBS (m1, m3 and m6) resulted in reduced luciferase activity, but was not significantly different from wild type demonstrating the central role played by the EBS element in the transcriptional activation of PTHrP P3 in response to cell signaling downstream of the T-cell receptor in transformed human T cells. (Figure 3a) . A modest induction of the protein-DNA complex C1 was also present with extracts from Jurkat T cells stimulated with PMA alone. Stimulation by ionomycin alone did not induce more protein-DNA complex formation when compared to controls. In all cases, the C1 complex was moderately reduced when the oligonucleotide contained a mutation in the GAS element (gas/ EBS), almost completely abrogated with the mutant oligonucleotide for EBS (GAS/ebs), and fully prevented when the double-mutant oligonucleotide (gas/ebs) was tested.
Combined PMA and ionomycin stimulation of Jurkat T cells induces a major protein-DNA complex containing Ets transcription factor(s)
Cooperative transcriptional activation of PTHrP P3 in Jurkat T cells by Mek-1 and Ets-1 mediated through an Ets-binding site Two mutants of the PTHrP P3-luc construct with a single mutation in EBS (m2) or a triple mutation in GAS, EBS and SBS (m7) were tested for luciferase activity simultaneously with the wild-type construct in all experimental groups. A significant (Figure 6b ). Reduction of luciferase activity relative to wild type ranged from 62 to 78% with the m2 PTHrP P3-luc construct and from 62 to 82% with the m7 PTHrP P3-luc construct. No significant difference in luciferase activity was observed between both mutant constructs in any of the experimental groups. These results support a cooperative effect of MAPK Mek-1 with the downstream transcription factor Ets-1 in the transcriptional activation of PTHrP P3 and suggest events occurred through a specific Ets-binding site. Measurement of PTHrP alternative promoter usage in the HTLV-1-positive cells revealed that P1 was minimally used in all HTLV-1-positive cell lines. This observation is consistent with other reports showing that PTHrP P1-derived transcripts were abundant in normal keratinocytes and squamous cell carcinomas, and were infrequently expressed in other tissues.
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Co-expression of
19,21 P3 promoter usage was favored over P2 in HTLV-1-infected cells (RV-ATL, MT-2 and SLB-1) expressing the highest PTHrP and lowest tax/rex mRNA copy numbers whereas the converse was observed in cells (Hut-102 and HT1-RV) expressing low PTHrP and high tax/rex mRNA. The latter finding may be explained by a variety of simple or combined mechanistic actions of Tax or Rex on transcriptional or post-transcriptional regulation of PTHrP gene expression. First, Tax can activate NF-kB signaling through various mechanisms, 47 and we identified two possible NF-kB DNA binding sites in the GC-rich PTHrP P2 promoter, one of which was able to bind NF-kB subunit p50 in RV-ATL cells (data not shown). Thus, elevated Tax expression in HTLV-1-infected cells might be associated with P2 transactivation via NF-kB, therefore leading to an increased ratio of P2 over P3-transcripts. Second, Tax can physically bind to transcription factors Ets-1 and Sp-1 to form a ternary complex, 32 but little is known regarding the affinity and transactivation potential of this complex relative to other Ets factor containing complexes. Thus, it is conceivable that the Ets-1/Sp1/Tax complex has higher affinity to the PTHrP P3 EBS but lower than other complexes that do not contain Tax leading to a lower P3 transcriptional activation when Tax is expressed at high levels.
ATLL cells typically exhibit the phenotype and cell signaling of activated T-cells. The MAPK signaling pathway can also be induced through active protein kinase C (PKC) and Sos following TCR engagement and IL-2 receptor activation. First, we examined by EMSA the formation of a protein/DNA complex using oligonucleotides containing the EBS PTHrP P3. We observed a constitutive and specific complex formation between an Ets transcription factor and P3 oligonucleotides in all HTLV-1 cell lines tested and the RV-ATL cells. The intensity of the complex correlated well with copy numbers of P3-derived mRNA transcripts in the cells. The complex formed with P3 EBS in RV-ATL cells was identical to that with an oligonucleotide containing an Ets-1 consensus sequence. Then, we mimicked cell signaling downstream of TCR activation by stimulating Jurkat T cells with PMA and ionomycin and observed a five-to six-fold induction of luciferase activity regulated by human PTHrP P3. Most of the transcriptional effect was attributable to an intact EBS located upstream of the TATA-box as demonstrated by a significant decrease in luciferase activity in Jurkat T cells transfected with constructs bearing a disrupted EBS. Mutation of the GAS and/or SBS did not significantly influence the luciferase activity in comparison to the wild-type construct. In addition, EMSA results showed that stimulation of Jurtkat T-cells with PMA and ionomycin induced complex formation on PTHrP P3 EBS, which was identical to that seen in HTLV-1-infected cells, including the RV-ATL cells. These results were consistent with previous reports that indicated upregulation of PTHrP gene expression by phorbol esters [48] [49] [50] and PKC activation, 51 and this effect was mediated by an Ets family transcription factor. The effect of ionomycin and PMA were additive on the induction of luciferase activity as would be expected by the synergistic activation of PKC by these agents. 52 The Raf/Mek-1/ERK1/2 pathway is activated by PKC upon T-cell activation and has been involved in PTHrP P3 transactivation in breast cancer cells. 51 Cotransfection of Jurkat T cells Regulation of PTHrP in ATLL V Richard et al with constitutive Mek-1 mutant and Ets-1 expression vectors resulted in up to a 40-fold induction of PTHrP P3-derived luciferase activity, and the induction was dramatically reduced by using P3 constructs bearing an EBS mutation whereas mutations in GAS and SBS did not affect the luciferase activity. Moreover, the protein/DNA complex formation observed by EMSA in all HTLV-1-positive cells was inducible by overexpression of active Mek-1 and Ets-1 as demonstrated in cotransfection experiments. Overall, our results showed that endogenous Ets-1 expression in Jurkat T cells as well as Mek-1 activity were insufficient to fully transactivate PTHrP P3, but this baseline transcription level could be synergistically enhanced by PMA and ionomycin stimulation in the presence of exogenous Ets-1.
These results support a model that chronically activated T-cells will have constitutive activation of the Ras/Mek-1/ERK1/ 2 coupled to high Ets-1 expression levels in order to upregulate PTHrP expression in ATLL cells. Other evidence to support this model comes from reports showing that NF-kB, 53 AP-1 54 and Jak/STAT 55 are constitutively active in primary ATLL cells in a Tax-independent manner and likely due to a cell signaling deregulation. Interestingly, all these signaling pathways are typically upregulated in activated T-cells. However, both Ets-1 expression and Ras/Mek-1/ERK1/2 activity have not been evaluated in ATLL. We evaluated the status of ERK-1/2 in HTLV-1-infected cell lines and RV-ATL cells and observed that a constitutive activation in ERK-1/2 was present in all cells examined (data not shown). Nevertheless, further investigation is necessary to correlate Ras/Mek-1/ERK1/2 pathway and Ets-1 expression with the level of PTHrP mRNA expression regulated by P3 in a subset of primary ATLL cells to fully validate the model.
In conclusion, our findings support the concept that PTHrP gene transcription upregulation in ATLL cells is attributable to transactivation of the third promoter (P3) via Ets-1 binding or other factors of the Ets family to a specific EBS response element located within the promoter and those events can occur upon activation of cell signaling downstream of the TCR independently of HTLV-1 Tax expression. This conclusion challenges the traditionally accepted paradigm that increased PTHrP expression and HHM in ATLL is due to Tax. Finally, further investigation is required to understand the underlying mechanisms involved in PTHrP P2 regulation in ATLL cells.
